Overview Bruker enables scientists and engineers to make groundbreaking post-genomic discoveries and develop new applications that improve people’s quality of life. Bruker’s high-performance scientific instruments and high-quality analytical and diagnostic solutions allow scientists to explore life and
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Overview Bruker enables scientists and engineers to make groundbreaking post-genomic discoveries and develop new applications that improve people’s quality of life. Bruker’s high-performance scientific instruments and high-quality analytical and diagnostic solutions allow scientists to explore life and
Are you an experienced IVD professional specializing in NGS-based IVD and CDx products? Ready to take on impactful new projects at the forefront of precision medicine? If this sounds like you and you are driven by
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)